The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters

This publication has 53 references indexed in Scilit:

• Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability
  Drug and Alcohol Dependence, 2006
• Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs
  Pharmacology & Therapeutics, 2005
• A multi‐center randomized trial of buprenorphine–naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network
  Addiction, 2005
• Buprenorphine for the management of opioid withdrawal
  Published by Wiley ,2004
• Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience
  The American Journal on Addictions, 2004
• Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
  New England Journal of Medicine, 2003
• Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
  Alcohol, Clinical and Experimental Research, 2001
• Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans
  Drug and Alcohol Dependence, 2001
• Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
  Drug and Alcohol Dependence, 2000
• Role of maintenance treatment in opioid dependence
  The Lancet, 1999